Shots:

• AXIM Biotechnologies and Auer Precision have partnered to manufacture two assays, T-POC TOTAL IgE Immunoassay and T-POC LACTOFERRIN Immunoassay, developed for point-of-care diagnosis of Dry Eye Disease (DED)
• The T-POC TOTAL IgE Immunoassay quantifies IgE in samples, facilitating clinicians in distinguishing underlying causes of a patient's eye condition and prescribing targeted treatments
• The T-POC LACTOFERRIN Immunoassay quantifies lactoferrin levels in patients, allowing clinicians to directly link low levels to DED caused by aqueous deficiency as well as the severity of DED based on lactoferrin levels

Ref: AXIM Biotechnologies Image: AXIM Biotechnologies

Related News:- AXIM Biotechnologies Entered into an Exclusive Commercial Agreement with Verséa Ophthalmics for Novel Ophthalmic Diagnostics Solutions

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com